AllianceBernstein’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

AllianceBernstein’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-130,450	Closed	-$870K	–	3226
2023 Q3	$870K	Hold	130,450	–	–	﹤0.01%	2313
2023 Q2	$1.18M	Buy	130,450 +70,650	+118%	+$623K	﹤0.01%	2197
2023 Q1	$435K	Sell	59,800 -101,586	-63%	-$754K	﹤0.01%	2628
2022 Q4	$1.18M	Buy	161,386 +116,386	+259%	+$864K	﹤0.01%	2196
2022 Q3	$348K	Buy	45,000 +31,800	+241%	+$270K	﹤0.01%	2800
2022 Q2	$90K	Buy	+13,200	New	+$101K	﹤0.01%	3135

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

AllianceBernstein's PNT Position: Q4 2023 in Review

AllianceBernstein sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 130,450 shares — an estimated $870K sold.

AllianceBernstein first reported a position in PNT in Q2 2022 and held it in 6 quarters. The position peaked at $1.18M in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

AllianceBernstein reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
AllianceBernstein sold 130,450 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $870K.
AllianceBernstein first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2022 and held it in 6 quarters.
AllianceBernstein's POINT Biopharma Global Inc. Common Stock position peaked at $1.18M in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on AllianceBernstein's 13F filing for Q4 2023, filed 14 Feb 2024.